Erica A. Peterson

Lenalidomide‐Dexamethasone as an Effective and Well‐Tolerated Treatment Option for Refractory Rosai‐Dorfman‐Destombes Disease: A Clinical and Pharmacophenomic Study

Emily Leung, Nicholas Ronald Fragola, Elliott W. Sharp, Rebecca A. Harrison et autres

A combined clinical and computational pharmacophenomic study from the Coastal Rare Inflammatory Diseases Program and Every Cure. Rosai-Dorfman-Destombes (RDD) disease is a rare histiocytic neoplasm that commonly presents with skin and subcutaneous masses, lymphadenopathy, and bone lesions [1]. Management is guided by …

ca, us (code pays fourni par la source)

Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada

Xiu Q. Wang, Kevin E. Shopsowitz, Jack Lofroth, Xuehai Wang et autres

ABSTRACT Background Lymphocytic variant hypereosinophilic syndrome (L‐HES) is a rare disorder characterized by persistent eosinophilia driven by aberrant T‐cell populations. Diagnosis remains challenging due to the lack of standardized diagnostic criteria. Methods We retrospectively analyzed 18 patients diagnosed with L‐HES between 2016 …

ca (code pays fourni par la source)

The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still’s disease, and COVID-19 cytokine storm

Mariam Goubran, Caroline Spaner, Sophie Stukas, Adi Zoref‐Lorenz et autres

Cytokine storm syndromes such as hemophagocytic lymphohistiocytosis (HLH), Adult-onset Still's disease (AOSD), and COVID-19 cytokine storm (CCS) are characterized by markedly elevated inflammatory cytokines. However clinical measurement of serum cytokines is not widely available. This study examined the clinical utility of C-reactive …

ca, us, il (code pays fourni par la source)

Rosai-Dorfman-Destombes disease in adults: a single center experience

Emily Leung, Collin Pryma, Stephen F. Murphy, Rebecca A. Harrison et autres

ca, us (code pays fourni par la source)

The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset Still’s disease, and COVID-19 cytokine storm

Mariam Goubran, Caroline Spaner, Sophie Stukas, Adi Zoref‐Lorenz et autres

ca, us, il (code pays fourni par la source)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series

Nicholas L.J. Chornenki, Heather McPhaden, Erica A. Peterson, C. Benjamin Lai et autres

Background: While anticoagulation therapy is highly effective at treating venous thromboembolism, some patients can develop rapidly progressive thrombosis in multiple organs or sites despite therapeutic anticoagulation. Effective strategies to manage life-threatening thrombosis in these patients are elusive. Objectives: We describe our experience …

ca (code pays fourni par la source)

Inflammatory Markers in Hemophagocytic Lymphohistiocytosis - a Single Centre Study

Caroline Spaner, Mariam Goubran, Sophie Stukas, Kam Shojania et autres

BACKGROUND Hemophagocytic lymphohistiocytosis (HLH) has significant clinical and biochemical overlap with other cytokine storm syndromes including Adult-Onset Still's disease (AOSD) and COVID-19 cytokine storm (CCS). Diagnosis of HLH is based largely on the HLH-2004 criteria which carry certain limitations. Many of the …

ca, il, us (code pays fourni par la source)

Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination

Agnes Lee, Muntadhar Al Moosawi, Erica A. Peterson, Rita McCracken et autres

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) adenoviral vector vaccination. In British Columbia (BC), Canada, a provincial clinical care pathway was developed to guide clinicians in evaluating for VITT among patients who …

ca (code pays fourni par la source)

Patient characteristics and long–term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism

Robert A. Schmidt, Alaa Al Zaki, Nikolas Desilet, Elena Szefer et autres

ca (code pays fourni par la source)

Update from the clinic: what’s new in the diagnosis of cancer-associated thrombosis?

Erica A. Peterson, Agnes Lee

Malignancy is associated with a high risk of venous thromboembolism (VTE), and treatment with anticoagulant therapy is associated with a high risk of bleeding. Thus, accurate and timely VTE diagnosis in cancer patients is essential for identifying individuals who would benefit from …

ca (code pays fourni par la source)

Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome

Charles Q. Choi, Daniél V. Møller, Julia Tan, Carol Dou et autres

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

ca (code pays fourni par la source)

Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated thrombosis.

Robert A. Schmidt, Alaa Alzaki, Nikolas Desilet, Namali Ratnaweera et autres

10057 Background: Cancer associated thrombosis (CAT) is a common complication of malignancies. However, little is known about the clinical course of CAT beyond the initial treatment period of 3 to 6 months. This information is important for clinicians and patients to inform …

ca (code pays fourni par la source)